Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in CVKD — Cadrenal Therapeutics, Inc.

CIK 1214717 BOSTON, MA
Back to CVKD Full portfolio

Position in CVKD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$63,540
-$47,184 QoQ
Shares Held
19,024
-12.0% QoQ
Ownership
0.533%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 18 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CVKD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. CVKD ranks #465 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in CVKD

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $63,540 19,024
2026-03-31 $110,724 21,626
2025-12-31 $98,499 14,528
2025-09-30 $175,778 12,710
2025-06-30 $153,154 12,710
2025-03-31 $213,075 12,086
2024-12-31 $152,926 10,554
2024-06-30 $28,929 61,554
2024-03-31 $26,147 42,865
2023-12-31 $28,671 38,745
2023-09-30 $26,346 38,745